Olfactory Training As a Treatment for Olfactory Dysfunction Post COVID-19

NCT ID: NCT05384561

Last Updated: 2024-12-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-05-31

Study Completion Date

2025-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Olfactory dysfunction is a defining symptom of COVID-19 infection. Studies have demonstrated improved olfaction in patients with post infectious olfactory dysfunction after an olfactory training (OT). The aim of this study is to assess the clinical outcomes of olfactory training (12 weeks) therapy in the treatment of persistent olfactory dysfunctions after COVID-19. Specially, we aim to compare the effectiveness of two different olfactory training (different odors).

A group will train themselves with 4 scents (rose, orange, clove and eucalyptus) and another group with 4 different scents (cheese, coffee, strawberries and lemon). Olfaction sensory evaluation will be performed by using different olfaction tests (Sniffin' Sticks and UPSIT) and complete questionnaires to assess olfactory perception and particularly parosmia and phantosmia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients who meet the criteria, who have agreed to participate in this research project and sign the consent form will be placed in one of the following two groups:

● Experimental group (olfactory training)

1. Initial meeting: Each participant will be asked for a session of approximately 1:30 h which will take place in a ventilated room in the laboratory of Dr. Johannes Frasnelli at UQTR. During the hour preceding this evaluation, subjects will be asked not to smoke, eat or drink anything other than water and not to wear perfume. A research assistant will be responsible for completing the various tests. During this meeting, the following tests will be done:

* Data collection (case report form): medical and socio-demographic questionnaire that will be used for data analysis.
* A nasal obstruction criterion scale - NOSE
* A subjective questionnaire on the impact of OD on quality of life - sQOD-NS
* Chemosensory Dysfunction Home Test - TMSC
* The UPSIT 40 test
* The Sniffin' Sticks test
* Test to assess the manifestation of parosmia and phantosmia
* Teaching on the olfactory rehabilitation kit and explanation of the training protocol.
2. Treatment (12 weeks): Following the initial meeting, patients can begin training:

■ Participants will bring their training kit with them following the olfactory evaluation.
3. Final meeting: After 12 weeks of treatment, an appointment will be scheduled with the participant. The olfactory evaluation will be done as described in the initial meeting. During the hour preceding this evaluation, subjects will be asked not to smoke, eat or drink anything other than water and not to wear perfume. A research assistant will be responsible for administering the various tests. During this meeting, the following tests will be done:

* A subjective questionnaire on the impact of OD on quality of life - sQOD-NS
* Chemosensory Dysfunction Home Test - TMSC
* The UPSIT 40 test
* The Sniffin' Sticks test
* Test to assess the manifestation of parosmia and phantosmia

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hyposmia COVID-19 Parosmia Anosmia SARS-CoV-2 Infection

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Olfactory training Chemosensory impairments Persistent smell impairment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Chemosensory training group 1

For 12 weeks, morning and evening, smell four odors namely eucalyptol, phenyl ethanol, Orange, and eugenol, for a total of five minutes per session.

Group Type EXPERIMENTAL

Smell training

Intervention Type OTHER

For 12 weeks, morning and evening, smell four different odors or four odorless substances for a total of five minutes per session.

Chemosensory training group 2

For 12 weeks, morning and evening, smell four odors namely coffee aroma, cheese aroma, strawberries, and limon, for a total of five minutes per session.

Group Type EXPERIMENTAL

Smell training

Intervention Type OTHER

For 12 weeks, morning and evening, smell four different odors or four odorless substances for a total of five minutes per session.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Smell training

For 12 weeks, morning and evening, smell four different odors or four odorless substances for a total of five minutes per session.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Chemosensory training group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient diagnosed positive for COVID-19 with persistent olfactory dysfunction
* Willing and able to provide written informed consent
* Understand and read the French language
* Have an internet connection and a working email address

Exclusion Criteria

* Anosmia and hyposmia pre-covid-19
* Be known chronic rhinosinusitis with or without nasal polyposis
* Have received radiotherapy or chemotherapy for Head and Neck Tumors
* Have a diagnosis of Alzheimer's, Parkinson's, multiple sclerosis or any other neurodegenerative disease 5. Have a brain tumor or ENT diagnosis 6. History of naso-sinus surgery; 7. History of traumatic brain injury
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Université du Québec à Trois-Rivières

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Johannes A Frasnelli, PhD

Role: PRINCIPAL_INVESTIGATOR

Université du Québec à Trois-Rivières

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Université du Québec à Trois-Rivières

Trois-Rivières, Quebec, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Johannes A Frasnelli, PhD

Role: CONTACT

Phone: 18193765011

Email: [email protected]

Frank Cloutier, PhD

Role: CONTACT

Phone: 18193765011

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Frank Cloutier, PhD

Role: primary

Simon Bérubé, Med Student

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OTTODC192022JFUQTR

Identifier Type: -

Identifier Source: org_study_id